Therapy Areas: Respiratory
ValiRx Plc licenses VAL401 to Ambrose Healthcare for rare disease treatments
5 December 2023 - London-based life science company ValiRx Plc (AIM: VAL) on Tuesday announced an exclusive Option Agreement through its joint venture, ValiSeek Limited, to license VAL401 to Ambrose H...
ANGLE plc introduces Portrait+ CTC staining kit at San Antonio Breast Cancer Symposium
5 December 2023 - Liquid biopsy company ANGLE plc (AIM:AGL) ( OTCQX:ANPCY) announced on Tuesday that it introduced its Portrait+ CTC staining kit at the San Antonio Breast Cancer Symposium (SABCS). Th...
Dupixent shows significant COPD exacerbation reduction in Phase 3 trial, accelerating FDA submission
27 November 2023 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that Dupixent (dupilumab) demonstrated a substantial 34% reduction in chronic obstructive ...
GenFleet Therapeutics announces Chinese regulatory acceptance of GFH925 New Drug Application and Priority Review designation granted
27 November 2023 - GenFleet Therapeutics, a China-based clinical-stage biotechnology company, announced on Friday that the New Drug Application (NDA) for GFH925 (IBI351) has been accepted by the Cente...
Broncus Hangzhou signs Equity Transfer Agreement with Hangzhou Jingliang shareholders
24 November 2023 - Broncus (2216.HK), a US-based medical device company in the field of interventional pulmonology, announced on Thursday that its wholly owned subsidiary, Broncus Hangzhou has signed ...
Innovent's IBI351 New Drug Application receives Chinese regulatory approval
24 November 2023 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Thursday that the Center for Drug Evaluation (CDE) of the National Medical Products Adm...